The optimum management of arthropathies
- PMID: 3056695
- DOI: 10.2165/00003495-198836030-00007
The optimum management of arthropathies
Abstract
The aims in management of an arthropathy are to relieve symptoms, preserve function, and control the disease process. Drugs are an important, although not the only, part of any therapeutic regimen enabling us to achieve these aims. Although each individual requires a unique strategy, there is a logical progression from first-line agents to second-line agents. Third-line agents and experimental methods are reserved for aggressive or life-threatening disease. The choice of agent in each group is personal preference, but many agents have high adverse effect profiles, and close monitoring is essential.
Similar articles
-
Second-line drugs for arthropathies.Practitioner. 1991 Oct;235(1507):787-90. Practitioner. 1991. PMID: 1800986 Review. No abstract available.
-
Management of hepatitis C virus-related arthritis.BioDrugs. 2001;15(9):573-84. doi: 10.2165/00063030-200115090-00002. BioDrugs. 2001. PMID: 11580301 Review.
-
Familial arthropathy in Saudi Arabian children: demographic, clinical, and biochemical features.Semin Arthritis Rheum. 2007 Feb;36(4):256-61. doi: 10.1016/j.semarthrit.2006.08.008. Epub 2006 Sep 22. Semin Arthritis Rheum. 2007. PMID: 16996580
-
[Normal therapeutic regimen in personal cases of psoriatic arthropathy].Rev Esp Reum Enferm Osteoartic. 1968 Oct;12(8):264-7. Rev Esp Reum Enferm Osteoartic. 1968. PMID: 5736092 Spanish. No abstract available.
-
Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.Eur Cytokine Netw. 2000 Dec;11(4):669-76. Eur Cytokine Netw. 2000. PMID: 11125312
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical